NCT06546007 2025-06-11
BioMolCTC
Rarecells Diagnostics SAS
Recruiting
Clinical Trials
17 trialsNCT06488365 2025-03-11
Cytophone
Cytoastra
Phase NA Recruiting
NCT06807502 2025-03-11
PROBE-CTC
ScreenCell
Phase NA Recruiting
NCT06043661 2023-09-21
Early Detection of Breast Cancer
Datar Cancer Genetics Inc
Unknown
NCT05437679 2023-09-05
CHARTER
Angle plc
Terminated
NCT03427450 2023-06-05
HOMING
Angle plc
Completed
NCT02742259 2019-03-26
VPCA-B+PIV
Celsee Diagnostics
Withdrawn
NCT03013868 2018-08-16
CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System
MiCareo Taiwan Co., Ltd.
Unknown
NCT03434912 2018-08-16
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy
MiCareo Taiwan Co., Ltd.
Unknown
NCT03476122 2018-04-02
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer
CellMaxLife
Unknown
NCT02412462 2017-06-28
Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy
Alethia Biotherapeutics
Phase 1 Completed
NCT02904135 2017-03-23
Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients
MiCareo Taiwan Co., Ltd.
Completed
NCT02904161 2017-03-23
Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer
MiCareo Taiwan Co., Ltd.
Completed
NCT01701050 2017-03-08
COMETI P2
Janssen Diagnostics, LLC
Completed
NCT01943500 2017-02-15
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Viatar LLC
Completed
NCT02647164 2016-01-06
The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring
GenoSaber
Unknown
NCT01129336 2014-05-20
MACS1295
Novartis
Phase 4 Completed